201 related articles for article (PubMed ID: 9660801)
21. IGFBP-3 and IGFBP-5 associate with the cell binding domain (CBD) of fibronectin.
Beattie J; Kreiner M; Allan GJ; Flint DJ; Domingues D; van der Walle CF
Biochem Biophys Res Commun; 2009 Apr; 381(4):572-6. PubMed ID: 19236847
[TBL] [Abstract][Full Text] [Related]
22. Insulin-like growth factor binding protein-3 prevents retinoid receptor heterodimerization: implications for retinoic acid-sensitivity in human breast cancer cells.
Schedlich LJ; O'Han MK; Leong GM; Baxter RC
Biochem Biophys Res Commun; 2004 Jan; 314(1):83-8. PubMed ID: 14715249
[TBL] [Abstract][Full Text] [Related]
23. Mutagenesis of basic amino acids in the carboxyl-terminal region of insulin-like growth factor binding protein-5 affects acid-labile subunit binding.
Firth SM; Clemmons DR; Baxter RC
Endocrinology; 2001 May; 142(5):2147. PubMed ID: 11316783
[TBL] [Abstract][Full Text] [Related]
24. Characterization of insulin-like growth factor binding protein-3 (IGFBP-3) binding to human breast cancer cells: kinetics of IGFBP-3 binding and identification of receptor binding domain on the IGFBP-3 molecule.
Yamanaka Y; Fowlkes JL; Wilson EM; Rosenfeld RG; Oh Y
Endocrinology; 1999 Mar; 140(3):1319-28. PubMed ID: 10067859
[TBL] [Abstract][Full Text] [Related]
25. Nonsecreted insulin-like growth factor binding protein-3 (IGFBP-3) can induce apoptosis in human prostate cancer cells by IGF-independent mechanisms without being concentrated in the nucleus.
Bhattacharyya N; Pechhold K; Shahjee H; Zappala G; Elbi C; Raaka B; Wiench M; Hong J; Rechler MM
J Biol Chem; 2006 Aug; 281(34):24588-601. PubMed ID: 16793770
[TBL] [Abstract][Full Text] [Related]
26. Insulin-like growth factor-binding protein-3 activates a phosphotyrosine phosphatase. Effects on the insulin-like growth factor signaling pathway.
Ricort JM; Binoux M
J Biol Chem; 2002 May; 277(22):19448-54. PubMed ID: 11940579
[TBL] [Abstract][Full Text] [Related]
27. Structural and functional evidence for the interaction of insulin-like growth factors (IGFs) and IGF binding proteins with vitronectin.
Kricker JA; Towne CL; Firth SM; Herington AC; Upton Z
Endocrinology; 2003 Jul; 144(7):2807-15. PubMed ID: 12810534
[TBL] [Abstract][Full Text] [Related]
28. Phosphorylation of insulin-like growth factor binding protein-3 by deoxyribonucleic acid-dependent protein kinase reduces ligand binding and enhances nuclear accumulation.
Schedlich LJ; Nilsen T; John AP; Jans DA; Baxter RC
Endocrinology; 2003 May; 144(5):1984-93. PubMed ID: 12697706
[TBL] [Abstract][Full Text] [Related]
29. Role of insulin-like growth factor binding protein-3 in breast cancer cell growth.
Schedlich LJ; Graham LD
Microsc Res Tech; 2002 Oct; 59(1):12-22. PubMed ID: 12242693
[TBL] [Abstract][Full Text] [Related]
30. Identification of the extracellular matrix binding sites for insulin-like growth factor-binding protein 5.
Parker A; Clarke JB; Busby WH; Clemmons DR
J Biol Chem; 1996 Jun; 271(23):13523-9. PubMed ID: 8662813
[TBL] [Abstract][Full Text] [Related]
31. The effects of insulin-like growth factor binding protein-3 (IGFBP-3) on T47D breast cancer cells enriched for IGFBP-3 binding sites.
Mishra S; Murphy LJ
Mol Cell Biochem; 2004 Dec; 267(1-2):83-9. PubMed ID: 15663189
[TBL] [Abstract][Full Text] [Related]
32. Differential insulin-like growth factor (IGF)-independent interactions of IGF binding protein-3 and IGF binding protein-5 on apoptosis in human breast cancer cells. Involvement of the mitochondria.
Perks CM; McCaig C; Holly JM
J Cell Biochem; 2000 Oct; 80(2):248-58. PubMed ID: 11074596
[TBL] [Abstract][Full Text] [Related]
33. Rapid apoptosis induction by IGFBP-3 involves an insulin-like growth factor-independent nucleomitochondrial translocation of RXRalpha/Nur77.
Lee KW; Ma L; Yan X; Liu B; Zhang XK; Cohen P
J Biol Chem; 2005 Apr; 280(17):16942-8. PubMed ID: 15731112
[TBL] [Abstract][Full Text] [Related]
34. Chondrocytes from osteoarthritic cartilage have increased expression of insulin-like growth factor I (IGF-I) and IGF-binding protein-3 (IGFBP-3) and -5, but not IGF-II or IGFBP-4.
Olney RC; Tsuchiya K; Wilson DM; Mohtai M; Maloney WJ; Schurman DJ; Smith RL
J Clin Endocrinol Metab; 1996 Mar; 81(3):1096-103. PubMed ID: 8772582
[TBL] [Abstract][Full Text] [Related]
35. Growth inhibition by insulin-like growth factor-binding protein-3 in T47D breast cancer cells requires transforming growth factor-beta (TGF-beta ) and the type II TGF-beta receptor.
Fanayan S; Firth SM; Butt AJ; Baxter RC
J Biol Chem; 2000 Dec; 275(50):39146-51. PubMed ID: 10993898
[TBL] [Abstract][Full Text] [Related]
36. Insulin-like growth factor (IGF) binding protein-3 inhibits type 1 IGF receptor activation independently of its IGF binding affinity.
Ricort JM; Binoux M
Endocrinology; 2001 Jan; 142(1):108-13. PubMed ID: 11145572
[TBL] [Abstract][Full Text] [Related]
37. Insulin-like growth factor-binding protein 3 induces caspase-dependent apoptosis through a death receptor-mediated pathway in MCF-7 human breast cancer cells.
Kim HS; Ingermann AR; Tsubaki J; Twigg SM; Walker GE; Oh Y
Cancer Res; 2004 Mar; 64(6):2229-37. PubMed ID: 15026367
[TBL] [Abstract][Full Text] [Related]
38. Differential effects of insulin-like growth factor binding proteins-1, -2, -3, and -6 on cultured growth plate chondrocytes.
Kiepe D; Ulinski T; Powell DR; Durham SK; Mehls O; Tönshoff B
Kidney Int; 2002 Nov; 62(5):1591-600. PubMed ID: 12371959
[TBL] [Abstract][Full Text] [Related]
39. Decreased caveolin-1 levels contribute to fibrosis and deposition of extracellular IGFBP-5.
Yamaguchi Y; Yasuoka H; Stolz DB; Feghali-Bostwick CA
J Cell Mol Med; 2011 Apr; 15(4):957-69. PubMed ID: 20345844
[TBL] [Abstract][Full Text] [Related]
40. Insulin-like growth factor-binding protein-5 enters vesicular structures but not the nucleus.
Jurgeit A; Berlato C; Obrist P; Ploner C; Massoner P; Schmölzer J; Haffner MC; Klocker H; Huber LA; Geley S; Doppler W
Traffic; 2007 Dec; 8(12):1815-1828. PubMed ID: 17892529
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
